PMN-MDSCs which were originated from immature myeloid cells of the bone marrow could migrate to TME to promote resistance to CD8 + cells and enhance the immune escape of the tumor via production of immunosuppressive enzymes such as Arg-1 and iNOS. This evidence concerns the gene ARG1 and neoplasm.